治疗相关神经内分泌前列腺癌伴鳞状分化中18F-FDG PET/CT发现PSMA阴性广泛转移
62岁男性前列腺癌患者经手术、放疗及激素治疗5年后出现背痛加重,血清前列腺特异性抗原极低(<1.0 ng/mL)而神经元特异性烯醇化酶升高(23.35 ng/mL)。双示踪剂PET/CT中68Ga-PSMA PET/CT未见复发或转移,18F-FDG PET/CT显示广泛高代谢骨病灶及膈脚后淋巴结病变,活检证实为治疗相关神经内分泌前列腺癌伴鳞状分化。该罕见表型表现为典型PSMA阴性及FDG高摄取,强调18F-FDG PET/CT在去分化前列腺癌中的诊断潜力。
要点
- 前列腺癌治疗后PSA极低但NSE升高时需警惕神经内分泌分化。
- 68Ga-PSMA PET/CT阴性而18F-FDG PET/CT可显示广泛转移。
- 活检证实治疗相关神经内分泌前列腺癌伴鳞状分化,呈PSMA阴性、FDG高摄取。
核心结论
- 治疗相关神经内分泌前列腺癌伴鳞状分化呈典型PSMA阴性及FDG高摄取,18F-FDG PET/CT在去分化前列腺癌中具有诊断潜力。
研究设计与样本
- 个案报道:62岁男性前列腺癌患者,接受前列腺切除术、放疗及激素治疗共5年。
主要发现
- 患者因背痛加重3个月就诊,血清前列腺特异性抗原极低(<1.0 ng/mL),神经元特异性烯醇化酶升高(23.35 ng/mL)。
- 68Ga-PSMA PET/CT未见复发或转移,18F-FDG PET/CT显示广泛高代谢骨病灶及膈脚后淋巴结病变。
- 活检证实为治疗相关神经内分泌前列腺癌伴鳞状分化,该罕见表型呈PSMA阴性及FDG高摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 62-year-old man had prostate cancer treated for 5 years with prostatectomy, radiation, and hormonal therapy. He presented with worsening back pain for 3 months. Serum prostate-specific antigen was very low (<1.0 ng/mL), while neuron-specific enolase was elevated (23.35 ng/mL), raising suspicion of neuroendocrine differentiation. Dual-tracer PET/CT was performed. 68 Ga-PSMA PET/CT showed no recurrence or metastasis, while 18 F-FDG PET/CT revealed widespread hypermetabolic bone lesions and retrocrural nodal disease. Biopsy confirmed treatment-related neuroendocrine prostate cancer with squamous differentiation. This rare phenotype exhibited typical PSMA-negativity and intense FDG uptake. It emphasizes the diagnostic potential of 18 F-FDG PET/CT in dedifferentiated prostate cancers.
引用
- Li Y, Gao X, Yang J, et al. PSMA-negative Widespread Metastases Identified by 18 F-FDG PET/CT in Treatment-related Neuroendocrine Prostate Cancer With Squamous Differentiation. Clin Nucl Med. 2025. PMID: 40804770. doi:10.1097/RLU.0000000000006106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。